187 related articles for article (PubMed ID: 6481470)
1. 131I total body scan and serum thyroglobulin assay in the follow-up of surgically treated patients affected by differentiated thyroid carcinoma.
Panza N; Lombardi G; Minozzi M; Salvatore M; Claudio F; Mariano A; Macchia V
J Nucl Med Allied Sci; 1984; 28(1):9-12. PubMed ID: 6481470
[No Abstract] [Full Text] [Related]
2. Thyroglobulin measurement vs iodine 131 total-body scan for follow-up of well-differentiated thyroid cancer.
Aiello DP; Manni A
Arch Intern Med; 1990 Feb; 150(2):437-9. PubMed ID: 2105703
[TBL] [Abstract][Full Text] [Related]
3. [Follow-up care for differentiated thyroid cancer].
Hüfner M; Reiners C
Dtsch Med Wochenschr; 1986 Nov; 111(45):1732-4. PubMed ID: 3536387
[No Abstract] [Full Text] [Related]
4. Critical evaluation of serum thyroglobulin levels and I-131 scans in post-therapy patients with differentiated thyroid carcinoma: concise communication.
Echenique RL; Kasi L; Haynie TP; Glenn HJ; Samaan NA; Hill CS
J Nucl Med; 1982 Mar; 23(3):235-40. PubMed ID: 7062137
[TBL] [Abstract][Full Text] [Related]
5. Thyroglobulin measurements in the follow-up of patients with differentiated thyroid carcinoma: comparison with quantitative radioactive iodine uptake measurements and total body scans.
Bolk JH; Bussemaker JK; Nieuwenhuijzen Kruseman AC; De Vijlder JJ; Goslings BM
Neth J Med; 1985; 28(9):340-6. PubMed ID: 4047268
[No Abstract] [Full Text] [Related]
6. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
[TBL] [Abstract][Full Text] [Related]
7. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
[TBL] [Abstract][Full Text] [Related]
8. Serum thyroglobulin in differentiated thyroid carcinoma.
Ericsson UB; Tegler L; Lennquist S; Christensen SB; Ståhl E; Thorell JI
Acta Chir Scand; 1984; 150(5):367-75. PubMed ID: 6485689
[TBL] [Abstract][Full Text] [Related]
9. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.
Bachelot A; Leboulleux S; Baudin E; Hartl DM; Caillou B; Travagli JP; Schlumberger M
Clin Endocrinol (Oxf); 2005 Mar; 62(3):376-9. PubMed ID: 15730423
[TBL] [Abstract][Full Text] [Related]
10. [The thyroglobulin level in blood: a reliable indicator of metastasis in the follow-up study of patients with functioning thyroid carcinoma].
Sluiter WJ; Sijperda A; Piers DA; Reitsma WD; Fleuren GJ; Oosterhuis JW; Vermey A; Doorenbos H
Ned Tijdschr Geneeskd; 1983 Jun; 127(26):1133-8. PubMed ID: 6888573
[No Abstract] [Full Text] [Related]
11. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma.
Frasoldati A; Pesenti M; Gallo M; Caroggio A; Salvo D; Valcavi R
Cancer; 2003 Jan; 97(1):90-6. PubMed ID: 12491509
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
[TBL] [Abstract][Full Text] [Related]
14. [Postoperative follow-up in differentiated carcinoma of the thyroid gland].
Pandolfi C
Minerva Med; 1986 Jun; 77(27):1317-9. PubMed ID: 3725155
[TBL] [Abstract][Full Text] [Related]
15. [The value of serum thyroglobulin determination in the after-care of patients with differentiated thyroid neoplasms].
Hüfner M; Pollmann H; Grussendorf M; Schenk P
Schweiz Med Wochenschr; 1980 Feb; 110(5):159-62. PubMed ID: 7361086
[TBL] [Abstract][Full Text] [Related]
16. [The use of 131I in the combined modality therapy of highly differentiated cancer of the thyroid gland].
Baranauskas ZL; Mamontov VV; Valutskas KK
Med Radiol (Mosk); 1989 Oct; 34(10):31-4. PubMed ID: 2811625
[TBL] [Abstract][Full Text] [Related]
17. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
Schlumberger M
J Nucl Med; 1992 Jan; 33(1):172-3. PubMed ID: 1571042
[No Abstract] [Full Text] [Related]
18. [Follow up of thyroglobulin levels in patients with surgically treated, highly differentiated thyroid cancer].
Szántó J; Vincze B; Sinkovits I; Karika Z; Daubner K; Péter I; Kazatsay I; Eckhardt S
Orv Hetil; 1989 Aug; 130(32):1695-9. PubMed ID: 2780041
[TBL] [Abstract][Full Text] [Related]
19. Charcoal suspension tattoo localization for differentiated thyroid cancer recurrence.
Hartl DM; Chami L; Al Ghuzlan A; Leboulleux S; Baudin E; Schlumberger M; Travagli JP
Ann Surg Oncol; 2009 Sep; 16(9):2602-8. PubMed ID: 19551443
[TBL] [Abstract][Full Text] [Related]
20. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]